Electromed, Inc. (ELMD)

ASE – Real Time Price. Currency in USD

41.46

+1.41 (3.52%)

At close: Jun 26, 2026, 4:00 PM EDT

41.46

0.00 (0.00%)

After-hours: Jun 26, 2026, 5:05 PM EDT

13.06.2026

Electromed: Strong Margins, Strong Growth, Large Runway

Electromed is rated 'buy' due to accelerating growth, margin expansion, and a large underpenetrated bronchiectasis market. ELMD benefits from a new CMS rule and a recently approved bronchiectasis drug, both driving increased disease awareness and streamlined clinician adoption. Gross margin improved to 78.5%, operating margin rose to 20.4%, and net income reached a record $3.0 million in Q3 FY 2026.

03.06.2026

Is Electromed (ELMD) a Solid Growth Stock? 3 Reasons to Think "Yes"

Electromed (ELMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

02.06.2026

Best Momentum Stocks to Buy for June 2nd

GOLD, ELMD and TPR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 2nd, 2026.

02.06.2026

New Strong Buy Stocks for June 2nd

GOLD, ELMD, TPR, PLGO and CRGY have been added to the Zacks Rank #1 (Strong Buy) List on June 2nd, 2026.

01.06.2026

Electromed, Inc. (ELMD) Hits Fresh High: Is There Still Room to Run?

Electromed (ELMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

21.05.2026

3 Medical Instrument Stocks Exploring GenAI to Tackle Industry Woes

GenAI is reshaping medical instruments as Electromed, Globus Medical and Intuitive Surgical navigate M&A and market pressures.

19.05.2026

Electromed, Inc. (ELMD)'s Technical Outlook is Bright After Key Golden Cross

Electromed, Inc. (ELMD) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ELMD's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.

Videos

No Data

There is no data to display

Press releases

12.05.2026

Electromed, Inc. Announces Record Financial Performance in Fiscal 2026 Third Quarter

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Record Financial Performance in Fiscal 2026 Third Quarter.

10.02.2026

Electromed, Inc. Announces Record Financial Performance in Fiscal 2026 Second Quarter

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Record Financial Performance in Fiscal 2026 Second Quarter.

20.11.2025

Electromed, Inc. to Participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference

New Prague, Minnesota--(Newsfile Corp. - November 20, 2025) - Electromed, Inc. (NYSE American: ELMD) ("Electromed" or the "Company"), a leader in innovative airway clearance technologies, today announced that it will participate in NobleCon21 - Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference being held at Florida Atlantic University in Boca Raton, Florida, on Wednesday, December 3, 2025. Jim Cunniff, Electromed's President and Chief Executive Officer, will present at 5:00 pm ET.

12.11.2025

Electromed, Inc. Announces First Quarter Fiscal 2026 Results

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed Reports First Quarter Fiscal 2026 Results.

Electromed, Inc. (ELMD)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Electromed, Inc. (ELMD)

Electromed: Strong Margins, Strong Growth, Large Runway